Denosumab versus placebo as adjuvant treatment for women with early-stage breast cancer at high risk of disease recurrence (D-CARE): An international, placebo-controlled, randomized, double-blind phase III clinical trial.

被引：0
|
作者：
Goss, Paul E.
Barrios, Carlos H.
Chan, Arlene
Finkelstein, Dianne M.
Iwata, Hiroji
Martin, Miguel
Braun, Ada
Ding, Beiying
Maniar, Tapan
Coleman, Robert E.
机构：
[1] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
[2] PUCRS Sch Med, Porto Alegre, RS, Brazil
[3] Curtin Univ, Mt Hosp, Perth, WA 6845, Australia
[4] Aichi Canc Ctr Hosp, Dept Breast Oncol, Nagoya, Aichi 464, Japan
[5] Univ Complutense, Inst Invest Sanitaria Gregario Maranon, E-28040 Madrid, Spain
[6] Amgen Inc, Thousand Oaks, CA 91320 USA
[7] YCR Sheffield Canc Res Ctr, Canc Res UK Inst Canc Studies, Sheffield, S Yorkshire, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS662
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Denosumab versus placebo as adjuvant treatment for women with early-stage breast cancer who are at high risk of disease recurrence (D-CARE): An international, randomized, double-blind, placebo-controlled phase III clinical trial.
    Goss, Paul Edward
    Barrios, Carlos H.
    Bell, Richard
    Finkelstein, Dianne M.
    Iwata, Hiroji
    Martin, Miguel
    Braun, Ada H.
    Ke, Chunlei
    Maniar, Tapan
    Coleman, Robert Edward
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [2] Denosumab versus placebo as adjuvant treatment for women with early-stage breast cancer at high risk of disease recurrence (D-CARE): An international, randomized, double-blind, placebo-controlled phase 3 clinical trial
    Goss, P. E.
    Barrios, C. H.
    Chan, A.
    Finkelstein, D. M.
    Iwata, H.
    Martin, M.
    Braun, A.
    Ke, C.
    Maniar, T.
    Coleman, R. E.
    CANCER RESEARCH, 2012, 72
  • [3] A randomized, double-blind, placebo-controlled multicenter phase III study comparing denosumab with placebo as adjuvant treatment for women with early-stage breast cancer who are at high risk of disease recurrence (D-CARE).
    Goss, P. E.
    Barrios, C. H.
    Bell, R.
    Finkelstein, D.
    Iwata, H.
    Martin, M.
    Braun, A. H.
    Dansey, R. D.
    Coleman, R. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [4] A Phase 3 Randomized, Double Blind, Placebo-Controlled Multicenter Study Comparing Denosumab with Placebo as Adjuvant Treatment for Women with Early-Stage Breast Cancer Who Are at High Risk of Disease Recurrence (D-CARE).
    Goss, P. E.
    Barrios, C. H.
    Bell, R.
    Finkelstein, D.
    Iwata, H.
    Martin, M.
    Braun, A.
    Ke, C.
    Maniar, T.
    Braun, S.
    Dansey, R.
    Coleman, R. E.
    CANCER RESEARCH, 2011, 71
  • [5] DENOSUMAB VERSUS PLACEBO AS ADJUVANT TREATMENT FOR WOMEN WITH EARLY-STAGE BREAST CANCER AT HIGH RISK OF DISEASE RECURRENCE (D-CARE)
    Chan, A.
    Goss, P.
    Barrios, C.
    Finkelstein, D. M.
    Iwata, H.
    Martin, M.
    Coleman, R.
    Braun, A.
    Zhou, Y.
    Maniar, T.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 : 53 - 53
  • [6] DENOSUMAB VERSUS PLACEBO AS ADJUVANT TREATMENT FOR WOMEN WITH EARLY-STAGE BREAST CANCER AT HIGH RISK OF DISEASE RECURRENCE (D-CARE): AN IN PROGRESS, PHASE 3 CLINICAL TRIAL
    Coleman, R. E.
    Barrios, C.
    Bell, R.
    Finkelstein, D. M.
    Iwata, H.
    Martin, M.
    Braun, A.
    Ke, C.
    Maniar, T.
    Goss, P. E.
    ANNALS OF ONCOLOGY, 2012, 23 : 115 - 115
  • [7] Adjuvant denosumab in early breast cancer: First results from the international multicenter randomized phase III placebo controlled D-CARE study.
    Coleman, Robert E.
    Finkelstein, Dianne
    Barrios, Carlos H.
    Martin, Miguel
    Iwata, Hiroji
    Glaspy, John A.
    Zhou, Ying
    Jandial, Danielle
    Chan, Arlene
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [8] Bone Health Outcomes from the International, Multicenter, Randomized, Phase 3, Placebo-Controlled D-CARE Study Assessing Adjuvant Denosumab in Early Breast Cancer
    Coleman, Robert
    Zhou, Ying
    Jandial, Danielle
    Cadieux, Benoit
    Chan, Arlene
    ADVANCES IN THERAPY, 2021, 38 (08) : 4569 - 4580
  • [9] Bone Health Outcomes from the International, Multicenter, Randomized, Phase 3, Placebo-Controlled D-CARE Study Assessing Adjuvant Denosumab in Early Breast Cancer
    Robert Coleman
    Ying Zhou
    Danielle Jandial
    Benoit Cadieux
    Arlene Chan
    Advances in Therapy, 2021, 38 : 4569 - 4580
  • [10] Phase III study of apatinib in advanced gastric cancer: A randomized, double-blind, placebo-controlled trial.
    Qin, Shukui
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345